EODData

SHG, 605116: Aurisco Pharmaceutical Co Ltd

31 Dec 2025
LAST:

25.05

CHANGE:
 0.30
OPEN:
25.86
HIGH:
25.86
ASK:
0.00
VOLUME:
3.0M
CHG(%):
1.18
PREV:
25.35
LOW:
24.95
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Dec 2525.8625.8624.9525.053.0M
30 Dec 2524.5025.9124.5025.356.68M
29 Dec 2524.7425.3924.5824.805.11M
26 Dec 2523.8624.6923.8224.455.93M
25 Dec 2523.8723.9523.3823.904.28M
24 Dec 2522.9824.1322.8623.887.89M
23 Dec 2522.0423.1922.0023.034.76M
22 Dec 2522.1422.3021.9522.041.76M
19 Dec 2522.1122.3022.0022.251.32M
18 Dec 2521.8822.1121.7522.081.08M

PROFILE

Name:Aurisco Pharmaceutical Co Ltd
About:Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid preparations are used for the treatment of hypercholesterolemia or atherosclerotic cardiovascular diseases; tenofovir used for the treatment of HIV-1 infection and chronic hepatitis B; pregabalin preparations are used to treat neuropathic pain, fibromyalgia, epilepsy, etc.; brivaracetam preparations are used to treat epilepsy; abiraterone acetate preparation for the treatment of prostate cancer; enzalutamide preparation for the treatment of prostate cancer; and dydrogesterone preparations are used to treat dysmenorrhea, endometriosis, irregular menstrual cycle, etc. In addition, the company provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Sector:Healthcare
Industry:Biotechnology
Address:Badu Industrial Park Zone, Tiantai, China, 317200
Website:https://www.aurisco.com
ISIN:CNE1000042S4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:22.55 
Forward P/E:18.82 
PEG Ratio:18.82 
Price to Sales:5.98 
Price to Book:3.82 
Profit Margin:0.26 
Operating Margin:0.36 
Return on Assets:0.08 
Return on Equity:0.18 
DivYield:0.01 
Div/Share:0.29 
Revenue:1.624B 
EBITDA:506.46M 
Shares:406.2M 
Market Cap:10.175B 

TECHNICAL INDICATORS

MA5:24.711.4%
MA10:23.685.8%
MA20:22.899.4%
MA50:22.839.7%
MA100:22.979.1%
MA200:22.1713.0%
STO9:77.78
STO14:80.05 
RSI14:79.52 
WPR14:-8.00 
MTM14:3.00
ROC14:0.14 
ATR:0.68 
Week High:25.913.4%
Week Low:22.869.6%
Month High:25.913.4%
Month Low:21.5113.0%
Year High:26.335.1%
Year Low:18.7034.0%
Volatility:3.27 

RECENT DIVIDENDS

Date Amount
20 Jun 2025$0.29
06 Jun 2024$0.22
22 May 2023$0.16
06 Jun 2022$0.13